Drugs / Dianeal Low-Calcium
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT03801226 | Dec 2018 → May 2019 | symptomatic heart failure | Yale University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Dianeal Low-Calcium | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03801226 ↗ |
| Route | Other | “participants with end-stage renal disease on peritoneal dialysis (PD) underwent randomization and crossover to either a 2-hour dwell with 1 L DSR solution or standard PD...” PMID 31910658 ↗ Jan 2020 |